GSK secures rights to Bayer drugs
GlaxoSmithKline the Anglo American pharmaceuticals group has acquired rights to a new class of osteoporosts treatments discovered by Bayer, the German chemicals group. The experimental drugs work in
GlaxoSmithKline the Anglo American pharmaceuticals group has acquired rights to a new class of osteoporosts treatments discovered by Bayer, the German chemicals group. The experimental drugs work in